You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Long-acting β2 agonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tiotropium + Olodaterol Versus Inhaled Corticosteroids +

Active, not recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium (Tio)
  • +4 more
  • Taipei, China
    National Tawain University Hospital
Jan 9, 2023

Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Brussels, Belgium
    Erasme University Hospital
Jun 23, 2023

Exacerbation Risk in Asthma

Completed
  • Asthma
  • White Plains, New York
    eMax Health
Aug 12, 2022

Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Taiwan, China
    Health Data Research Center, National Taiwan University
Jan 3, 2023

Tiotropium and Olodaterol in Comparison to Triple Therapy

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium and Olodaterol (Tio+Olo)
  • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
  • Andover, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Tiotropium and Olodaterol in Comparison to LABA/ICS

Completed
Has Results
  • COPD
  • Watertown, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Asthma Trial in Nyíregyháza (Administration via pressurized metered dose inhaler (pMDI))

Recruiting
  • Asthma
  • Administration via pressurized metered dose inhaler (pMDI)
  • Nyíregyháza, Hungary
    Simplex Kft
Mar 14, 2022

Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)

Completed
  • Asthma
  • CHF1535 200/6 µg
  • BDP 100 µg
  • Pisa, Italy
    Cardio-Thoracic and Vascular Dept, University of Pisa
Oct 28, 2021

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma:

Recruiting
  • Asthma
  • Mepolizumab
  • Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA)
  • Lund, Skane, Sweden
    The Lung and Allergy Clinic, Skåne University Hospital (SUS)
Jan 16, 2023

Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

Completed
  • Asthma
  • Fluticasone with salmeterol
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Oct 12, 2022

Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

Recruiting
  • Asthma
  • To compare in both treatment arms the percentage of patients controlled at week 52.
  • Inca, Baleares, Spain
  • +16 more
Jun 16, 2023

Asthma Trial in Glendale, London (AZD8630, Placebo)

Recruiting
  • Asthma
  • Tempe, Arizona
  • +14 more
Jan 23, 2023

Asthma Trial in Suresnes (Hair sampling, Hair's drug concentrations)

Active, not recruiting
  • Asthma
  • Hair sampling
  • Hair's drug concentrations
  • Suresnes, France
    Foch Hospital
Aug 2, 2022

Cisgender Female Patients Who Start on Long Acting Cabotegravir

Not yet recruiting
  • Hiv
  • Cabotegravir Injection [Apretude]
  • Orlando, Florida
  • +2 more
Nov 17, 2023

Asthma Trial in Worldwide (CHF 5259 plus Foster 100/6 µg, Foster 100/6 µg)

Completed
  • Asthma
  • CHF 5259 plus Foster 100/6 µg
  • Foster 100/6 µg
  • Dupnitza, Bulgaria
  • +43 more
Apr 6, 2021

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

Not yet recruiting
  • HIV-1-infection
  • +2 more
  • CAB + RPV
  • (no location specified)
Nov 16, 2022

Cardiovascular Events in Chronic Obstructive Pulmonary Disease

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
    • Aarhus, Denmark
      Aarhus Universitets hospital Skejby
    Apr 29, 2021

    Asthma Trial in Worldwide (QAX576, Placebo)

    Completed
    • Asthma
    • QAX576
    • Placebo
    • Phoenix, Arizona
    • +51 more
    Dec 11, 2020

    South Korea Using Medical Records to Look at Different

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting Muscarinic Antagonists (LAMA)
    • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
    • Seoul, Korea, Republic of
      Konkuk University Medical Center
    Feb 8, 2022

    HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

    Not yet recruiting
    • HIV
    • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
    • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
    • (no location specified)
    Nov 13, 2023

    Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

    Not yet recruiting
    • Idiopathic CD4 Lymphopenia
    • Recombinant human interleukin (IL) 7-hyFc
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

    Recruiting
    • HIV-1-infection
    • Kisumu, Kenya
    • +6 more
    Feb 1, 2023

    Pediatric Growth Hormone Deficiency, Growth Disorders Trial in Sapporo (Somavaratan (VRS-317))

    Terminated
    • Pediatric Growth Hormone Deficiency
    • Growth Disorders
    • Somavaratan (VRS-317)
    • Sapporo, Japan
      Hokkaido University Hospital
    Jul 22, 2022